In the field of cardiovascular diseases, some studies suggest that GDF11 decreases the risk of cardiovascular events and death in patients with stable ischaemic heart disease and improves aging-related cardiac hypertrophy [2, 94]. This evidence concerns the gene GDF11 and cardiovascular disorder.